Role of 4-hydroxy-2,3-nonenal in the pathogenesis of fibrosis

BioFactors

Volumn 24, Issue 1-4, 2005, Pages 229-236

  Chiarpotto, Elena ^a   Castello, Laura ^a   Leonarduzzi, Gabriella ^a   Biasi, Fiorella ^a   Poli, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

4 Hydroxy 2,3 nonenal; Activator protein 1; Fibrosis; Oxidative stress; Transforming growth factor 1

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE DERIVATIVE; ANTIOXIDANT; BENZENESULFONIC ACID DERIVATIVE; CYTOKINE; DNA; N ETHYLMALEIMIDE; THIOL GROUP; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIETETICS; DNA BINDING; FIBROSIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA; MURINAE;

EID: 28644451510     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520240127     Document Type: Article

References (30)

1. J. Armendariz-Borunda, C.P. Simkevitch, N. Roy, R. Raghow, A.H. Kang and J.M. Seyer, Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression, Biochem. J. 304 (1994), 817-824.
2. S.P. Atamas and B. White, The role of chemokines in the pathogenesis of scleroderma, Curr. Opin. Rheumatol. 15 (2003), 772-777.
3. P. Bedossa, K. Houglum, C. Trautwein, A. Holstege and M. Chojkier, Stimulation of collagen alpha (I) gene expression is associated with lipid peroxidation in hepatocellular injury: A link to tissue fibrosis? Hepatology 19 (1994), 1262-1271.
4. L. Bahadori, J. Milder, L. Gold and M. Botney, Active macrophage-associated TGF-beta co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries, Am. J. Pathol. 146 (1995), 1140-1149.
5. F. Calabrese, M. Valente, C. Giacometti, E. Pettenazzo, L. Benvegnu, A. Alberti, A. Gatta and P. Pontisso, Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology, J. Gastroenterol. Hepatol. 18 (2003), 1302-1308.
6. S. Camandola, A. Scavazza, G. Leonarduzzi, F. Biasi, E. Chiarpotto, A. Azzi and G. Poli, Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-kB in cells of the macrophage lineage, BioFactors 6 (1997), 173-179.
7. S. Chen, B. Jim and F.N. Ziyadeh, Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up, Semin. Nephrol. 23 (2003), 532-543.
8. E. Chiarpotto, C. Allasia, F. Biasi, G. Leonarduzzi, F. Ghezzo, G. Berta and G. Poli, Down-modulation of nuclear localisation and pro-fibrogenic effect of 4-hydroxy-2,3-nonenal by thiol- and carbonyl-reagents, Biochim. Biophys. Acta. 1584 (2002), 1-8.
9. M. Chojkier, K. Houglum, J. Solis-Herruzo and D.A. Brenner, Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? J. Biol. Chem. 264 (1989), 16957-16962.
10. M.P. Czech, Differential effects of sulfhydryl reagents on activation and deactivation of the fat cells hexose transport system, J. Biol. Chem. 251 (1976) 1164-1170.
11. C.M. Dubois, M.H. Laprise, F. Blanchette, L.E. Gentry and R. Leduc, Processing transforming growth factor β1 precursor by human furin convertase, J. Biol. Chem. 270 (1995), 10618-10624.
12. S.E. Crawford, V. Stellmach, J.E. Murphy-Ullrich, S.M. Ribeiro, J. Lawler, R.O. Hynes, G.P. Boivin and N. Bouck, Thrombospondin-1 is a major activator of TGF-beta1 in vivo, Cell 93 (1998), 1159-1170.
13. M. Gulumian, The ability of mineral dusts and fibres to initiate lipid peroxidation. Part II: relationship to different particle-induced pathological effects, Redox Report 5 (2000), 325-351.
14. M.C. Hall, D.A. Young, J.G. Waters, A.D. Rowan, A. Chantry, D.R. Edwards and M. Clarks, The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-β1, J. Biol. Chem. 278 (2003), 10304-10313.
15. M.A. Haralson, Transforming growth factor beta, other growth factors and extracellular matrix, J. Lab. Clin. Med. 130 (1997), 455-458.
16. K. Hishikawa, T. Nakaki and T. Fujii, Transforming growth factor-β(1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells, Eur. J. Pharmacol. 385 (1999), 287-290.
17. S.J. Kim, F. Dehnez, K.Y. Kim, J.T Holt, M.B. Sporn and A.B. Roberts, Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences, J. Biol. Chem. 264 (1989), 19373-19378.
18. G. Leonarduzzi, A. Scavazza, F. Biasi, E. Chiarpotto, S. Camandola, S. Vogl, R. Dargel and G. Poli, The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis, FASEB J. 11 (1997), 851-857.
19. A.R. Lopez, J. Cook, P.L. Deininger and R. Derynk, Dominant negative mutants of transforming growth factor-beta 1 inhibit the secretion of different transforming growth factor-beta isoforms, Mol. Cell Biol. 12 (1992), 1674-1679.
20. J. Massagué, The transforming growth factor-beta family, Annu. Rev. Cell Biol. 6 (1990), 597-641.
21. J. Massagué, TGFbeta signaling: receptors, transducers, and Mad proteins, Cell 85 (1996), 947-950.
22. J.S. Munger, J.G. Harpel, P.E. Gleizes, R. Mazzieri, I. Nunes and D.B. Rifkin, Latent transforming growth factor-β: Structural features and mechanisms of activation, Kid. Int. 51 (1997), 1376-1382.
23. N. Nieto, S.L. Friedman and A.I. Cederbaum, Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species, Hepatology 35 (2002), 62-73.
24. C.S. Parker and A.A. Topol, Drosophila RNA polymerase II transcription factor contains promoter-region-specific DNA-binding activity, Cell 36 (1984), 357-369.
25. M. Parola, M. Pinzani, A. Casini, E. Albano, G. Poli, A. Gentilini, P. Gentilini and M.U. Dianzani, Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha (I) gene expression and synthesis in human liver fat storing cells, Biochem. Biophys. Res. Commun. 194 (1993), 1044-1050.
26. G. Poli and M. Parola, Oxidative damage and fibrogenesis, Free Radic. Biol. Med. 22 (1997), 287-305.
27. G. Poli and R.J. Schaur, 4-Hydroxynonenal in the pathomechanisms of oxidative stress, IUBMB Life 50 (2000), 315-321.
28. J. Rossert, C. Terraz-Durasnel and G. Brideau, Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy, Diabetes & Metabolism 26 (2000), 16-24.
29. Y. Sun and L.W. Oberley, Redox regulation of transcriptional activators, Free Radic. Biol. Med. 21 (1996), 335-348.
30. R.T. Yan and P.C. Maloney, Residues in the pathway through a membrane transporter, Proc. Natl. Acad. Sci. USA 92 (1995), 5973-5976.